Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pharmacological Therapy in Brugada Syndrome

View through CrossRef
Brugada syndrome (BrS) is a cardiac disease caused by an inherited ion channelopathy associated with a propensity to develop ventricular fibrillation. Implantable cardioverter defibrillator implantation is recommended in BrS, based on the clinical presentation in the presence of diagnostic ECG criteria. Implantable cardioverter defibrillator implantation is not always indicated or sufficient in BrS, and is associated with a high device complication rate. Pharmacological therapy aimed at rebalancing the membrane action potential can prevent arrhythmogenesis in BrS. Quinidine, a class 1A antiarrhythmic drug with significant Ito blocking properties, is the most extensively used drug for the prevention of arrhythmias in BrS. The present review provides contemporary data gathered on all drugs effective in the therapy of BrS, and on ineffective or contraindicated antiarrhythmic drugs.
Title: Pharmacological Therapy in Brugada Syndrome
Description:
Brugada syndrome (BrS) is a cardiac disease caused by an inherited ion channelopathy associated with a propensity to develop ventricular fibrillation.
Implantable cardioverter defibrillator implantation is recommended in BrS, based on the clinical presentation in the presence of diagnostic ECG criteria.
Implantable cardioverter defibrillator implantation is not always indicated or sufficient in BrS, and is associated with a high device complication rate.
Pharmacological therapy aimed at rebalancing the membrane action potential can prevent arrhythmogenesis in BrS.
Quinidine, a class 1A antiarrhythmic drug with significant Ito blocking properties, is the most extensively used drug for the prevention of arrhythmias in BrS.
The present review provides contemporary data gathered on all drugs effective in the therapy of BrS, and on ineffective or contraindicated antiarrhythmic drugs.

Related Results

Positive Brugada Challenge Test in V1R–V3R as a Predictor of Malignant Prognosis in Brugada Patients
Positive Brugada Challenge Test in V1R–V3R as a Predictor of Malignant Prognosis in Brugada Patients
BackgroundThe Brugada syndrome is a heterogeneous genetic disease that predisposes to life‐threatening ventricular tachyarrhythmias and sudden cardiac death (SCD). The only proven ...
Low-dose oral flecainide provocation test for Brugada syndrome: a case series
Low-dose oral flecainide provocation test for Brugada syndrome: a case series
Abstract Background Brugada syndrome is a rare, inherited cardiac disorder that predisposes individuals to life-threatening ventricular arrhythmi...
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Three in One: Systemic Lupus Erythematosus, HELLP Syndrome, and Antiphospholipid Syndrome: A Case Report and Literature Review
Abstract Introduction Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease commonly affecting women of reproductive age. Its overlap with HELLP syndrome (Hemolysi...
e0568 Followup of five patients with Brugada syndrome treated with ICD
e0568 Followup of five patients with Brugada syndrome treated with ICD
Objective To investigate clinical symptoms, episodes of arrhythmias and its therapy in patients with Brugada syndrome treated with implantable cardioverter-defibr...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Ablation of a life-threatening arrhythmia in a patient with Brugada syndrome
Ablation of a life-threatening arrhythmia in a patient with Brugada syndrome
Brugada syndrome is an autosomal dominant arrhythmogenic disease associated with an increased risk of ventricular fibrillation and sudden cardiac death. The mainstay of treatment i...
Metabolic syndrome and neuroprotection
Metabolic syndrome and neuroprotection
Introduction: over the years, the prevalence of metabolic syndrome has increased dramatically in developing countries as a major by-product of industrialization. Many factors, such...

Back to Top